Skip to content

Clinical research

Clinical trial sites in China

Clinical trial sites: one pin for each physical site that hosts trials, placed from the address on the trial registration.

  • Trial site
  • Group of pins (click to zoom)

Showing the 40,000 busiest of 45,895 located sites. The map holds only the first 40,000, so narrow the filters to see the rest.

Each pin is one trial site, placed on the map from the address on the trial registration, so it shows part of where trials are run, not all of it. A site with no located address has no pin. A site with a public page on Pharma Observatory links to it; other sites show name, place and trial count only.

Looking for contract research suppliers and CROs? Visit Contract Research Map

Looking to track new and ongoing clinical trials? Visit Trial Insights

Filters: Country: China Clear all

Trial sites by region

Select a bar to filter by region.

Scale
Trial sites by region
CategoryTrial sites
Asia-Pacific45,895

Top countries

Country of the site's address. Select a bar to filter.

Scale

Bar colour shows the country's region, as in the chart by region.

Trial sites by country
CategoryTrial sites
United States307,017
Germany73,166
France73,153
Italy48,417
China45,895
Japan38,740
Spain36,429
United Kingdom32,402

Trial sites

45,895 sites. Sites with a public page link to it on Pharma Observatory.

  • Tianjin Medical University Cancer Institue and Hospital Tianjin, Tianjin Municipality, China 1 trial
  • Tianjin Medical University Cancer Institute & Hosipital Tianjin, Tianjin Municipality, China 1 trial
  • Tianjin Medical University Cancer Institute & Hospital Tiyuan, China Ongoing trial 1 trial
  • Tianjin Medical University Cancer Institute & Hospital ( Site 0098) Tianjin, Tianjin Municipality, China 1 trial
  • Tianjin Medical University Cancer Institute & Hospital ( Site 0392) Tianjin, Tianjin Municipality, China Ongoing trial 1 trial
  • Tianjin Medical University Cancer Institute & Hospital ( Site 0505) Tianjin, Tianjin Municipality, China 1 trial
  • Tianjin Medical University Cancer Institute & Hospital ( Site 0606) Tianjin, Tianjin Municipality, China 1 trial
  • Tianjin Medical University Cancer Institute & Hospital ( Site 2447) Tianjin, Tianjin Municipality, China 1 trial
  • Tianjin Medical University Cancer Institute & Hospital ( Site 3103) Tianjin, Tianjin Municipality, China Ongoing trial 1 trial
  • Tianjin Medical University Cancer Institute & Hospital ( Site 3204) Tianjin, Tianjin Municipality, China Ongoing trial 1 trial
  • Tianjin Medical University Cancer Institute & Hospital ( Site 3209) Tianjin, Tianjin Municipality, China Ongoing trial 1 trial
  • Tianjin Medical University Cancer Institute & Hospital ( Site 4054) Tianjin, Tianjin Municipality, China Ongoing trial 1 trial
  • Tianjin Medical University Cancer Institute & Hospital ( Site 8035) Tianjin, Tianjin Municipality, China 1 trial
  • Tianjin Medical University Cancer Institute & Hospital (0606) Tianjin, Tianjin Municipality, China 1 trial
  • Tianjin Medical University Cancer Institute & Hospital - Breast Tumor Department Tianjin, Tianjin Municipality, China Ongoing trial 1 trial
  • Tianjin Medical University Cancer Institute & Hospital /ID# 156542 Tianjin, Tianjin Municipality, China Ongoing trial 1 trial
  • Tianjin Medical University Cancer Institute & Hospital /ID# 223550 Tianjin, Tianjin Municipality, China Ongoing trial 1 trial
  • Tianjin Medical University Cancer Institute & Hospital, Hepatobiliary Oncology Department Tianjin, West Lake District, China 1 trial
  • Tianjin Medical University Cancer Institute & Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer Tianjin, China Ongoing trial 1 trial
  • Tianjin Medical University Cancer Institute & Hospital-Biotherapy ( Site 1671) Tianjin, Tianjin Municipality, China 1 trial

Explore the data behind the map on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.